Histogenics (HSGX) Announces Approval of Merger by Stockholders at Special Meeting Sep 26, 2019 04:28PM
Histogenics Corporation Announces Approval of Merger by Stockholders at Special Meeting Sep 26, 2019 04:25PM
Histogenics Corporation Announces Adjournment of its Special Meeting to Thursday, September 26, 2019 Sep 12, 2019 09:15AM
Histogenics Corporation Announces Intent to Convene and Adjourn Its Special Meeting Sep 11, 2019 04:05PM
Histogenics (HSGX) to be Acquired by Ocugen Apr 8, 2019 07:07AM


Apr 8, 2019 07:00AM Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics